Abstract:OBJECTIVE:TGF-beta plays a key role in wound scarring. This study explored the possibility of using gene therapy to inhibit wound scarring by blocking TGF-beta signaling.METHODS:In vitro, human normal dermal fibroblasts were infected with recombinant adenoviruses of truncated TGF-beta receptor II (tTGF-betaRII, 100 pfu/cell) and beta-galactosidase (beta-gal, 100 pfu/cell), and their effects on regulating TGF-beta1 gene expression were analyzed by Northern blot. For gene therapy, beta-gal and tTGF-betaRII viruses (1 x 10(9) pfu)were injected intradermally at left and right side of dorsal skin of newborn Sprague-Dawley rats (n = 15) respectively. A full-thickness incisional wound (0.5 cm long) was created at the injection sites of each rat 2 days post-injection. An incisional wound was similarly created in the middle part of the dorsal skin of tTGF-betaRII transgenic mice (n = 5) and control mice (n = 5). Wound tissues of rats and mice were harvested at various time points post-wounding for histological and immunohistochemical analysis. Scar area in tissue section was measured by Image-Pro Plus software.RESULTS:Over-expression of tTGF-betaRII markedly reduced TGF-beta1 gene expression in dermal fibroblasts. Adenovirus mediated gene expression in skin reached a peak level 2 - 3 days post-injection, and decreased gradually at 5 - 7 days. Two weeks post-wounding, histology and quantitative analysis demonstrated that relative scar area in the wounds of transgenic mice and control mice were 136,969.8 +/- 66,339 and 474,641.6 +/- 227,396 respectively, the scar area of transgenic wounds was 29 percent of control area (P < 0.05). In all rats, wounds transfected with tTGF-betaRII gene healed with much less scarring (relative scar area 128,311.2 +/- 36,764.6) than control wounds (251,189.1 +/- 62,544.7) of the same rat, with a 45% reduction of scar area in average (P < 0.001). In addition, the tTGF-betaRII expression also decreased inflammation and TGF-beta1 production in treated wounds, and promoted the repair of panniculus muscle in treated wounds.CONCLUSIONS:Adenovirus mediated over-expression of tTGF-betaRII can block TGF-beta signaling and inhibit wound scarring, and thus can serve as a gene therapy strategy to control wound scarring.

Notch signal deficiency alleviates hypertrophic scar formation after wound healing through the inhibition of inflammation.

Co-transfection of Hepatocyte Growth Factor and Truncated TGF-β Type II Receptor Inhibit Scar Formation

Adenovirus-mediated METH1 gene expression inhibits hypertrophic scarring in a rabbit ear model.

[Blocking of Notch Signaling Decreased Scar Formation in Rabbit Ear Hypertrophic Scar Model].

Aberrant Notch signalling contributes to hypertrophic scar formation by modulating the phenotype of keratinocytes

Inhibition of Notch Intracellular Domain Suppresses Cell Activation and Fibrotic Factors Production in Hypertrophic Scar Fibroblasts Versus Normal Skin Fibroblasts.

Insufficient SIRT1 in macrophages promotes oxidative stress and inflammation during scarring

Notch Regulates Macrophage-Mediated Inflammation in Diabetic Wound Healing

Human-Specific Gene Chrfam7a Mediates M2 Macrophage Polarization Via The Notch Pathway To Ameliorate Hypertrophic Scar Formation

SHH induces macrophage oxidative phosphorylation and efferocytosis to promote scar formation

Emodin alleviates hypertrophic scar formation by suppressing macrophage polarization and inhibiting the Notch and TGF-β pathways in macrophages

Basic fibroblast growth factor reduces scar by inhibiting the differentiation of epidermal stem cells to myofibroblasts via the Notch1/Jagged1 pathway

Lipopolysaccharide Induces Skin Scarring Through the TLR4/Myd88 Inflammatory Signaling Pathway in Dermal Fibroblasts.

[Inhibiting Scar Formation in Rat Cutaneous Wounds by Blocking TGF-beta Signaling].

Notch1 signaling determines the plasticity and function of fibroblasts in diabetic wounds

Direct And Indirect Roles Of Macrophages In Hypertrophic Scar Formation

The regulatory role of the apelin/APJ axis in scarring: Identification of upstream and downstream mechanisms

Knockdown of CPEB1 and CPEB4 Inhibits Scar Formation via Modulation of TAK1 and SMAD Signaling

IL-17 Promotes Scar Formation by Inducing Macrophage Infiltration.

The role of ERK and JNK signaling in connective tissue growth factor induced extracellular matrix protein production and scar formation

Inhibition of FKBP10 Attenuates Hypertrophic Scarring Through Suppressing Fibroblast Activity and Extracellular Matrix Deposition.